💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Repros Therapeutics Inc. (RPRX)
« Back to company indexRPRX Chatter Timeline
Stock Ticker for RPRX
Most Active Tweeters for RPRX
| User | Tweets |
|---|---|
| @newsfilterio | 5 |
| @here_and_now_be | 5 |
| @RPRXsenzoku | 3 |
| @TradeWithAlerts | 3 |
| @WALLSTREETODDS_ | 3 |
Recent Tweets for RPRX
 |
@WALLSTREETODDS_ $RPRX Out of the 111 other times RPRX was up 1.7% during a trading day, 58% of the time it traded lower by the nex… https://t.co/TZt6nWC4Jc April 14th 2021, 11:04pm |
 |
@TradeWithAlerts Large Print $RPRX Size: 119500 Price: 42.78 Time: 1344 Amount: $5,112,210.00 April 14th 2021, 5:04pm |
 |
@newsfilterio Insider Sells Royalty Pharma's Shares $RPRX https://t.co/ry07OBIBtX April 14th 2021, 5:04pm |
 |
@OilStocker $RPRX @ $42.55 Insider Sells Royalty Pharma's Shares April 14th 2021, 5:04pm |
 |
@TradeOnTheWire1 $RPRX vol candle April 14th 2021, 5:04pm |
|
@TradeWithAlerts Large Print $RPRX Size: 114344 Price: 42.5 Time: 1310 Amount: $4,859,620.00 April 14th 2021, 5:04pm |
 |
@FoonerJ $RPRX investors finally realizing that Trodelvy got accelerated FDA approval. April 14th 2021, 2:04pm |
 |
@InsiderForms $RPRX Insider Reddoch James F. has Sold 359 Shares. Title :EVP Research; Investments Total Cost: $15,192.88 Buy/Se… https://t.co/ALHR0cTO0l April 14th 2021, 12:04pm |
|
@InsiderForms $RPRX Insider Lloyd George W. has Sold 449 Shares. Title :EVP Investments; GC Total Cost: $19,001.68 Buy/Sell : S… https://t.co/KyVaNcwQHR April 14th 2021, 12:04pm |
 |
@insiderbuyings $RPRX new insider selling: 449 shares. https://t.co/BTDnVNa6Ub April 14th 2021, 12:04pm |
 |
@fintel_io Insider Lloyd George W. reports selling 449 shares of $RPRX for a total cost of $19,001.68 https://t.co/vqgmlwWuby April 14th 2021, 11:04am |
 |
@InsiderAlerts4U $RPRX: New Insider Filing on Royalty Pharma plc's EVP, Research & Investments JAMES F. REDDOCH: https://t.co/y6CyN8SUmg April 14th 2021, 11:04am |
 |
@formwhisperscom #FWSells $RPRX Reddoch James F., EVP, Research & Investments of Royalty Pharma plc sold 359 shares on 2021-04-12. https://t.co/9Z70GtMuhp April 14th 2021, 11:04am |
|
@formwhisperscom #FWSells $RPRX Lloyd George W., EVP, Investments & GC of Royalty Pharma plc sold 449 shares on 2021-04-12. https://t.co/9Z70GtMuhp April 14th 2021, 11:04am |
|
@fintel_io Insider Reddoch James F. reports selling 359 shares of $RPRX for a total cost of $15,192.88 https://t.co/C7x3D4DADd April 14th 2021, 11:04am |
 |
@savage_swings $RPRX #Earnings 5/12 Interesting company. Lots of acquisitions. Chart looks to be nearing the bottom. Support at… https://t.co/nwBHW1dKxQ April 14th 2021, 2:04am |
 |
@Gambiste1 RT @obryanjf: There now I finally put 2 and 2 together, sooner than the Japanese fellow that is super quick on $RPRX I'm trying to get more… April 13th 2021, 11:04pm |
 |
@obryanjf $RPRX in case anyone is wondering how this applies to RP. my notes on Trodelvy are attached. A relatively minor co… https://t.co/hgp2u1D1KI April 13th 2021, 11:04pm |
|
@obryanjf There now I finally put 2 and 2 together, sooner than the Japanese fellow that is super quick on $RPRX I'm trying t… https://t.co/i9qaGq8mNm April 13th 2021, 10:04pm |
|
@WALLSTREETODDS_ $RPRX Out of the 62 other times RPRX was down 2.5% during a trading day, 58% of the time it traded higher by the n… https://t.co/w9QLj327Bm April 13th 2021, 5:04am |
|
@TradeWithAlerts Large Print $RPRX Size: 320447 Price: 41.23 Time: 1600 Amount: $13,212,029.81 April 12th 2021, 8:04pm |
 |
@DiscriminantBot RT @intratio: $RPRX https://t.co/yVzsFgz4Yx Royalty Pharma Plc The artificial intelligence has detected that this companie s stock price va… April 10th 2021, 10:04am |
 |
@here_and_now_be RT @crist_phd: $RPRX deal yesterday makes me think further about the potential in $ACTG which in addition to the legacy biz seems to be piv… April 9th 2021, 1:04pm |
 |
@crist_phd $RPRX deal yesterday makes me think further about the potential in $ACTG which in addition to the legacy biz seems… https://t.co/17EDBsW2yu April 9th 2021, 12:04pm |
|
@here_and_now_be $RPRX Royal Pharma came public in a 'golden age of medical research,' Jim Cramer says https://t.co/sxe1X26XKU https://t.co/99CFj6anFN April 9th 2021, 2:04am |
 |
@Gaahi4 BTW $RPRX is a really big CASH monster. On the other hand the present price is cheap isn’t it? https://t.co/Lq1976A6ez April 9th 2021, 12:04am |
 |
@RPRXsenzoku $RPRX THE EUROPEAN COMMISSION GRANTS MARKETING AUTHORIZATION FOR NEW SUBCUTANEOUS ADMINISTRATION OF TYSABRI® (NATA… https://t.co/eOhAcNBjoJ April 8th 2021, 10:04pm |
|
@RPRXsenzoku $RPRX FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Pr… https://t.co/Zo7PI0U51L April 8th 2021, 2:04pm |
 |
@deus_trader Optimus v4 2021-04-08 09:38 ET. Bought/Opened: $RPRX at $41.99. Royalty Pharma plc (CORP). Win Chance: 65%. Avg Wi… https://t.co/au6bm9E4BA April 8th 2021, 1:04pm |
 |
@StckPro $RPRX NEW ARTICLE : Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million… https://t.co/ZfXgNTlsxB April 8th 2021, 11:04am |
 |
@FlashAlert_me $RPRX [15s. delayed]: Issued Press Release on April 08, 07:40:00: Royalty Pharma Acquires OXLUMO™ Royalty Interest… https://t.co/PZNadxGxfK April 8th 2021, 11:04am |
 |
@stock_titan $RPRX Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million https://t.co/KMvKUi4QkU April 8th 2021, 11:04am |
|
@here_and_now_be RT @WALLSTREETODDS_: $RPRX Out of the 80 other times RPRX was down 2.2% during a trading day, 56% of the time it traded higher by the next… April 8th 2021, 3:04am |
|
@WALLSTREETODDS_ $RPRX Out of the 80 other times RPRX was down 2.2% during a trading day, 56% of the time it traded higher by the n… https://t.co/VdL3R1XZd1 April 8th 2021, 1:04am |
 |
@ONeillDemon Good timing for $ai $rprx for me... April 7th 2021, 1:04pm |
 |
@stockmarkettile @HiawathaGeronmo I’m thankful I bought $RPRX on the dip and I’m thankful you got in on the Royalty Pharma train with me ? April 5th 2021, 9:04pm |
|
@InsiderAlerts4U $RPRX: New Insider Filing on Royalty Pharma plc's Director BONNIE L BASSLER: https://t.co/5Fyq207PSY April 3rd 2021, 12:04am |
|
@newsfilterio $37,454.40 of shares acquired by Fernandez Henry A (Director), reported in a new form 4 filed with the SEC $RPRX https://t.co/RcSood75eT April 2nd 2021, 11:04pm |
|
@newsfilterio $37,454.40 of shares acquired by Bassler Bonnie L (Director), reported in a new form 4 filed with the SEC $RPRX https://t.co/WplGdV8ks6 April 2nd 2021, 9:04pm |
|
@newsfilterio Royalty Pharma Acquires Royalty Interest in Cabozantinib From GSK $RPRX https://t.co/wYtsjb3pqj April 2nd 2021, 6:04am |
 |
@Quantumup1 BofA $RPRX 's acquisition of a 3% royalty on Cabometyx sales adds yet another growing revenue stream. Launch in com… https://t.co/bP6yIoeQwm April 1st 2021, 7:04pm |
|
@StckPro $GSK $RPRX NEW ARTICLE : Royalty Pharma Buys Royalty Interest In Cabozantinib Products From GSK… https://t.co/VnYUS7CsFQ April 1st 2021, 5:04pm |
 |
@Briefingcom $RPRX: Royalty Pharma acquired a royalty interest in the cabozantinib products Cabometyx and Cometriq from... https://t.co/XNpBBGm4bm April 1st 2021, 1:04pm |
 |
@rosderek $RPRX seems pretty bullish about prospects of cabo $EXEL https://t.co/vKpBydjL87 April 1st 2021, 12:04pm |
|
@newsfilterio Royalty Pharma acquires royalty interest in cabozantinib from GSK $RPRX $GSK https://t.co/g4Rsc1kt0h April 1st 2021, 11:04am |
|
@RPRXsenzoku $RPRX ROYALTY PHARMA ACQUIRES ROYALTY INTEREST IN CABOZANTINIB FROM GSK https://t.co/dudZBd2wuo April 1st 2021, 11:04am |
 |
@sbwcws Royalty Pharma acquires royalty interest in cabozantinib from GlaxoSmithKline $RPRX $GSK April 1st 2021, 11:04am |
|
@FlashAlert_me $RPRX [15s. delayed]: Issued Press Release on April 01, 07:30:00: Royalty Pharma Acquires Royalty Interest in Caboz… https://t.co/d1hlxmwwKu April 1st 2021, 11:04am |
 |
@bthefirsttoknow $RPRX: Royalty Pharma Acquires Royalty Interest in Cabozantinib From GSK https://t.co/SsmXuu9Eyd April 1st 2021, 11:04am |
|
@stock_titan $RPRX Royalty Pharma Acquires Royalty Interest in Cabozantinib From GSK https://t.co/kFskHjxXnf April 1st 2021, 11:04am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
